name: Equine herpesvirus 1 Ab:Titr:Pt:CSF:SemiQn


name: Equine herpesvirus 2 Ab:Titr:Pt:Ser:SemiQn


name: Equine herpesvirus 3 Ab:Titr:Pt:Ser:SemiQn


name: Herpes simplex virus Ab:PrThr:Pt:Body fld:Ord


name: Infectious bronchitis virus JMK Ab:Titr:Pt:Ser:SemiQn


name: Legionella non pneumophila sp Ab:Titr:Pt:Ser:SemiQn


name: Salmonella typhi O D Ab:Titr:Pt:Ser:SemiQn


name: Tilt table study:Find:Pt:Cardiovascular system:Doc


name: Views^during surgery W contrast retrograde:Find:Pt:Abdomen>Kidney:Doc:XR


name: Chlamydia trachomatis L2 Ab.IgA:Titr:Pt:Ser:SemiQn:IF


name: Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM:Titr:Pt:Ser:SemiQn:IA


name: Cortisol^15M post dose corticotropin IM:MCnc:Pt:Ser/Plas:Qn


name: Saint Louis encephalitis virus Ab.IgG:PrThr:Pt:Ser:Ord


name: Leishmania chagasi K39 Ab:PrThr:Pt:Ser:Ord


name: Avian metapneumovirus A Ab:Titr:Pt:Ser:SemiQn:IA


name: Avian metapneumovirus B Ab:PrThr:Pt:Ser:Ord:IF


name: Equine herpesvirus 2 Ab.Neut:Titr:Pt:Ser:SemiQn:Neut


name: Infectious bronchitis virus JMK Ab:Titr:Pt:Ser:SemiQn:HAI


name: Avian metapneumovirus C Ab:PrThr:Pt:Ser:Ord


name: Figure associated with report or note:-:Pt:^Patient:-


name: Streptococcus sp:Prid:Pt:Isolate:Nom:Organism specific culture


name: Stem cell product given:Vol:Pt:^Patient:Qn


name: Bartonella henselae & Bartonella quintana Ab.IgM panel:-:Pt:CSF:-


name: Guidance for percutaneous drainage of abscess+placement of drainage catheter:Find:Pt:XXX:Doc:CT


name: Views^during electroconvulsive shock treatment:Find:Pt:Head>Brain:Doc:NM


name: Views runoff^W contrast IA:Find:Pt:Abdomen>Aorta.abdominal:Doc:RF.angio


name: Chlamydia trachomatis D+K Ab.IgG:PrThr:Pt:Ser:Ord


name: Multisection^WO contrast:Find:Pt:Lower extremity.right>Thigh vessels:Doc:MR.angio


name: Guidance for drainage+placement of drainage catheter:Find:Pt:XXX:Doc:RF


name: Views for bone density:Find:Pt:Whole body>Skeletal system.axial:Doc:NM


name: Guidance for deep biopsy:Find:Pt:XXX>Bone:Doc:US


name: Albumin:MRat:12H:Urine:Qn:Detection limit <= 20 mg/L


name: Views for blood flow^W Tc-99m DTPA IV:Find:Pt:Head>Brain:Doc:NM


name: Views quantitative for infarct^W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM


name: Views perfusion quantitative^W radionuclide IV:Find:Pt:Chest>Lung:Doc:NM


name: Herpes simplex virus:Prid:Pt:CSF:Nom:Shell vial culture


name: SURF1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Views perfusion^at rest+W adenosine+W Tl-201 IV:Find:Pt:Chest>Heart:Doc:NM


name: Influenza virus A Ab.IgG:PrThr:Pt:Ser:Ord


name: Influenza virus B Ab.IgG:PrThr:Pt:Ser:Ord


name: Clarithromycin 3.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Aspergillus flavus B Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Aspergillus fumigatus B Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Aspergillus nidulans H Ab:PrThr:Pt:Ser:Ord:Immune diffusion


name: Chlamydia trachomatis Ab.IgA & IgG & IgM:Imp:Pt:Ser:Nom


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Retroperitoneum:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Abdomen>Adrenal gland:Doc:MR


name: Views^W Tc-99m medronate IV:Find:Pt:XXX>Bone:Doc:NM


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Retroperitoneum:Doc:US


name: Views GE 3:Find:Pt:Lower extremity>Foot:Doc:XR


name: Views GE 4^W R-Bending + W L-Bending:Find:Pt:XXX>Spine:Doc:XR


name: View for scoliosis:Find:Pt:Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:XR


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Neck>Thyroid gland:Doc:RF


name: Multisection^WO & W contrast IV:Find:Pt:Abdomen>Superior mesenteric vessels:Doc:MR.angio


name: Multisection limited for graft:Find:Pt:Upper extremity.bilateral>Upper extremity vessel:Doc:US.doppler


name: Influenza virus A H6 RNA:ACnc:Pt:XXX:Qn:Probe.amp.tar


name: Immune complex:PrThr:Pt:Ser/Plas:Ord:Raji cell assay


name: Beta 2 glycoprotein 1 Ab.IgG:ACnc:Pt:Ser/Plas:Qn:IA


name: Borrelia burgdorferi Ab^1st specimen:ACnc:Pt:Ser:Qn:IA


name: Herpes simplex virus 1:PrThr:Pt:Vag:Ord:Organism specific culture


name: Herpes simplex virus 1 Ab:PrThr:Pt:Body fld:Ord


name: Herpes simplex virus 2:PrThr:Pt:Genital:Ord:Organism specific culture


name: Herpes simplex virus Ag:PrThr:Pt:Cvx:Ord:IF


name: Herpes virus 6 Ab.IgG:PrThr:Pt:Ser:Ord:IF


name: Margin involvement:Find:Pt:Prostate tumor:Nom:CAP cancer protocols


name: Invasive carcinoma.uninvolved margin distance.closest:Len:Pt:Breast tumor:Qn


name: Lymphocyte proliferation. 0.50 ug pokeweed mitogen stimulation:NRat:Pt:Bld:Qn


name: Periprostatic fat invasion:Prid:Pt:Specimen:Nom:CAP cancer protocols


name: Dominant nodule.additional dimension 2:Len:Pt:Prostate tumor:Qn


name: Margin(s) involved by invasive carcinoma:Find:Pt:Prostate tumor:Nom


name: Liver transplant anastomosis site:Anat:Pt:Hepatic artery:Nom


name: Liver transplant anastomosis site:Anat:Pt:Hepatic artery^Graft:Nom


name: Burkholderia sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: GNE gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: La Crosse virus Ab.IgM:Titr:Pt:Ser:SemiQn:IA


name: Insulin dependent diabetes mellitus:PrThr:Pt:^Patient:Ord


name: Prolactin^1H post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Prolactin^15M post dose TRH IV:ACnc:Pt:Ser/Plas:Qn


name: Borrelia burgdorferi 31kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Borrelia burgdorferi 34kD Ab.IgM:PrThr:Pt:Ser:Ord:IB


name: Adenosine monophosphate.cyclic/Creatinine^4H post XXX challenge:Ratio:Pt:Urine:Qn


name: Preferred activity setting - day or activity room:Find:Pt:^Patient:Ord:MDS


name: Ehrlichia chaffeensis Ab.IgG & IgM panel:Titr:XXX:Ser:SemiQn:IF


name: Protein & Glucose panel:-:Pt:Urine:-:Test strip


name: Chlamydia trachomatis+Neisseria gonorrhoeae rRNA:PrThr:Pt:Cvx:Ord:Probe


name: Cocal virus Ag:PrThr:Pt:XXX:Ord:Comp fix


name: Sjogrens syndrome-B extractable nuclear Ab:ACnc:Pt:Ser:Qn:IA


name: CASR gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: Isoniazid 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: Choriogonadotropin.beta subunit.free multiple of the median:Prctl:Pt:Ser/Plas:SemiQn


name: Date Rh immune globulin given:Date:Pt:^Patient:Qn


name: Lymphocyte proliferation. 2.0 ug phytohemagglutinin stimulation:NRat:Pt:Bld:Qn


name: Lymphocyte proliferation. 5 ug concanavalin A stimulation:NRat:Pt:Bld:Qn


name: Date of transfusion reaction:TmStp:Pt:^Patient:Qn


name: Medicare or comparable number:ID:Pt:^Patient:Nom


name: Change in communication &or hearing:Find:Pt:^Patient:Ord:MDS


name: History of prior stay at this nursing home:Find:Pt:^Patient:Ord:MDS


name: History of stay in mental retardation and developmental disabilities setting:Find:Pt:^Patient:Ord:MDS


name: Spends most time alone or watching TV:Find:Pt:^Patient:Ord:MDS


name: Wakens to toilet all or most nights:Find:Pt:^Patient:Ord:MDS


name: Self or family pays for full per diem:Find:Pt:^Patient:Ord:MDS


name: Uses other modes of expression:Find:Pt:^Patient:Ord:MDS


name: No mode of transfer:Find:Pt:^Patient:Ord:MDS


name: Alterability of physically abusive behavioral symptoms:Find:Pt:^Patient:Ord:MDS


name: Strong identification with past roles and life status:Find:Pt:^Patient:Ord:MDS


name: Resident perceives that daily routine (customary routine, activities) is very different from prior pattern in the community:Find:Pt:^Patient:Ord:MDS


name: Locomotion off unit - support provided during assessment period:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Change in urinary continence:Find:Pt:^Patient:Ord:MDS


name: Infections - none of above:Find:Pt:^Patient:Ord:MDS


name: Chest pain while doing usual activities:Find:Pt:^Patient:Ord:MDS


name: Number of D with at least 15M of speech language pathology and audiology services in the last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Stasis pressure injury stage:Find:Pt:^Patient:Nom:MDS


name: History of resolved ulcers:Find:Pt:^Patient:Ord:MDS


name: Activity preferences - cards or other games:Find:Pt:^Patient:Ord:MDS


name: Number of D hypnotic medication received:Num:Pt:^Patient:Qn:MDS


name: Total minutes of psychological therapy by any licensed mental health professional in the last 7D:Time:7D:^Patient:Qn:CMS Assessment


name: Bed rails - other types of side rails used:Find:Pt:^Patient:Ord:MDS


name: Therapy orders to begin in 1st 14D of stay:Find:Pt:^Patient:Ord:MDS


name: Other current or more detailed diagnoses & ICD9 codes^^^4:Prid:Pt:^Patient:Nom:MDS


name: Deprecated MDS full assessment form - version 2.0


name: Disease or condition diagnoses section:-:Pt:^Patient:-


name: Neurological diseases or conditions:-:Pt:^Patient:Set


name: Special treatments and procedures section:-:Pt:^Patient:-


name: Deprecated MDS quarterly assessment form - version 2.0


name: Bowel elimination pattern (quarterly):-:Pt:^Patient:Set


name: Ascaris lumbricoides adult Ab.IgG:ACnc:Pt:Ser:Qn


name: Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgG:Titr:Pt:Ser:SemiQn


name: Chlamydia trachomatis D+E+F+G+H+I+J+K Ab.IgM:Titr:Pt:Ser:SemiQn


name: 15 Beta, 17 Alpha-Dihydroxypregnanolone/Creatinine


name: ADL self performance or support (quarterly)


name: Advance directive - feeding restrictions


name: Alzheimer's or dementia special care unit


name: Archive facility identification number NPI


name: Bartonella henselae & Bartonella quintana Ab.IgG & IgM panel


name: Bartonella henselae & Bartonella quintana Ab.IgM panel


name: Basic metabolic panel & Glomerular filtration rate.predicted


name: Beta 2 globulin+Gamma globulin/Protein.total


name: Communication and hearing patterns section


name: Continence appliances and programs (quarterly)


name: Creatinine & Glomerular filtration rate.predicted panel


name: cycloSPORINE.monoclonal & polyclonal panel


name: Date background information form completed


name: Dehydration &or fluid maintenance trigger


name: Depth of invasion by tumor cannot be determined comment


name: Discharge potential and overall status section


name: Distance of invasive melanoma to closest deep margin


name: Distance of melanoma in situ to closest lateral margin


name: Dolichovespula maculata Ab.IgG.RAST class


name: Ehrlichia chaffeensis Ab.IgG & IgM panel


name: Fatty acid panel.very long chain C22-C26


name: Glycogen synthase I/Glycogen synthase.total


name: Guidance for change of dialysis catheter


name: Guidance for localization of bleeding site


name: Guidance for needle localization of mass


name: Histoplasma capsulatum H Ab band pattern


name: Histoplasma capsulatum M Ab band pattern


name: Horse hair+Horse dander Ab.IgE.RAST class


name: House dust Hollister Stier Ab.IgG.RAST class


name: Human prescription drug label with highlights


name: Identification and background information section


name: Intervention programs for mood, behavior and cognitive loss


name: Invasive carcinoma.uninvolved margin distance.closest


name: Invasive component size.additional dimension 2


name: Lymphocyte proliferation. 0.125 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 0.25 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 0.50 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 1.0 ug pokeweed mitogen stimulation


name: Lymphocyte proliferation. 10 ug concanavalin A stimulation


name: Lymphocyte proliferation. 2.0 ug phytohemagglutinin stimulation


name: Lymphocyte proliferation. 20 ug concanavalin A stimulation


name: Melanoma in situ.location relative to closest uninvolved lateral margin


name: Melanoma in situ.location relative to involved lateral margin


name: Number of D recreation therapy administered for greater than 15M


name: Number of D antianxiety medication received


name: Number of D diuretic medication received


name: Number of D hypnotic medication received


name: Number of D physician orders changed in last 14D


name: Nutritional approaches (quarterly RUG-III)


name: Parietaria officinalis Ab.IgE.RAST class


name: Physical functioning and stuctural problems section


name: Rat epithelium+Serum proteins+Urine proteins Ab.IgE.RAST class


name: Regional lymph nodes containing metastases


name: Resident assessment protocol 1--Delirium - proceed with care


name: Resident assessment protocol 1--Delirium - triggered


name: Resident assessment protocol 10--Activities - proceed with care


name: Resident assessment protocol 11--Falls - proceed with care


name: Resident assessment protocol 11--Falls - triggered


name: Resident assessment protocol 12--Nutritional status - triggered


name: Resident assessment protocol 13--Feeding tubes - proceed with care


name: Resident assessment protocol 13--Feeding tubes - triggered


name: Resident assessment protocol 14--Dehydration &or Fluid maint - proceed with care


name: Resident assessment protocol 14--Dehydration &or Fluid maint - triggered


name: Resident assessment protocol 15--Dental care - proceed with care


name: Resident assessment protocol 15--Dental care - triggered


name: Resident assessment protocol 17--Psychotropic drug - proceed with care


name: Resident assessment protocol 18--Physical restraints - proceed with care


name: Resident assessment protocol 18--Physical restraints - triggered


name: Resident assessment protocol 2--Cognitive loss - proceed with care


name: Resident assessment protocol 2--Cognitive loss - triggered


name: Resident assessment protocol 3--Visual function - proceed with care


name: Resident assessment protocol 3--Visual function - triggered


name: Resident assessment protocol 4--Communication - triggered


name: Resident assessment protocol 5--ADL functional &or rehab - proceed with care


name: Resident assessment protocol 5--ADL functional &or rehab - triggered


name: Resident assessment protocol 6--Urinary incontinence - proceed with care


name: Resident assessment protocol 6--Urinary incontinence - triggered


name: Resident assessment protocol 7--Psychosocial - proceed with care


name: Resident assessment protocol 7--Psychosocial - triggered


name: Resident assessment protocol 8--Mood state - proceed with care


name: Resident assessment protocol 8--Mood state - triggered


name: Resident assessment protocol 9--Behavioral symptoms - proceed with care


name: Resident assessment protocol 9--Behavioral symptoms - triggered


name: Resident assessment protocol summary section


name: Special treatments and procedures section


name: Special treatments, procedures and programs


name: Triglycerides to HDL Cholesterol Ratio Measurement


name: Views AP (KUB & upright) & upright chest


name: Views AP (supine KUB & upright) & PA upright chest


name: Views for endocrine tumor multiple areas


name: Bartonella henselae & Bartonella quintana Ab.IgG panel


name: W gastrografin PO and W barium contrast PR


name: Comprehensive metabolic panel & Glomerular filtration rate.predicted


name: Assessment using PHQ-9 depression questionnaire


name: Views qualitative+quantitative for infarct


name: Therapy supplement for Medicare PPS section


name: Resident assessment protocol 17--Psychotropic drug - triggered


name: Resident assessment protocol 12--Nutritional status - proceed with care


name: Invasive component size.additional dimension 1


name: Advance directive - other treatment restrictions:Find:Pt:^Patient:Ord:MDS


name: Alkaline phosphatase.heat stable/Alkaline phosphatase.total


name: CIAS1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Number of D antipsychotic medication received


name: Nursing rehabilitation and restorative care


name: Resident assessment protocol 10--Activities - triggered


name: Resident assessment protocol 4--Communication - proceed with care


name: Distance of invasive melanoma to closest lateral margin


name: Insertion or replacement of implantable pressure sensor with lead for intracardiac or great vessel hemodynamic monitoring


name: Implantation or replacement of subcutaneous device for intracardiac or great vessel hemodynamic monitoring


name: Implantation of monitoring device with formation of subcutaneous pocket and connection to intracardiac pressure sensor (lead)


name: Resurfacing hip, total, acetabulum and femoral head


name: Hip resurfacing arthroplasty, partial, femoral head


name: Removal of catheter(s) from cranial cavity or tissue


name: Placement of intracerebral catheter(s) via burr hole(s)


name: Convection enhanced delivery of intracerebral catheter(s)


name: Stereotactic placement of intracerebral catheter(s)


name: Operation on lens, not elsewhere classified


name: Implantation of intraocular telescope prosthesis


name: Percutaneous ablation of lung lesion or tissue


name: Thoracoscopic ablation of lung lesion or tissue


name: Other and unspecified ablation of lung lesion or tissue


name: Endoscopic insertion or replacement of bronchial valve(s), single lobe


name: Intrabronchial airflow redirection valve


name: Endoscopic removal of bronchial device(s) or substances


name: Endoscopic insertion of other bronchial device or substances


name: Biologic Lung Volume Reduction NOS (BLVR)


name: Repair of ventricular septal defect with prosthesis, closed technique


name: Noninvasive programmed electrical stimulation [NIPS]


name: Repositioning of (cardiac device) lead(s)


name: Repositioning of (defibrillator) lead(s)


name: Removal of cardiac device/pulse generator without replacement


name: Removal of implantable hemodynamic pressure sensor (lead) and monitor device


name: Removal without replacement of cardiac resynchronization defibrillator device


name: Repositioning of implantable hemodynamic pressure sensor (lead) and monitor device


name: Revision of cardioverter/defibrillator (automatic) pocket


name: Revision of pocket for intracardiac hemodynamic monitoring


name: Implantation of defibrillator with epicardial patches, formation of abdominal fascia pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with epicardial patches, formation of pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with epicardial patches, formation of subcutaneous pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads (epicardial patches), formation of pocket (abdominal fascia) (subcutaneous), any transvenous leads, intraoperative procedures for evaluation of lead signals, and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads, formation of abdominal fascia pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads, formation of pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation of defibrillator with leads, formation of subcutaneous pocket, any transvenous leads, intraoperative procedures for evaluation of lead signals and obtaining defibrillator threshold measurements


name: Implantation or replacement of the total automatic cardioverter/defibrillator system by lateral thoracotomy techniques


name: Implantation or replacement of the total automatic cardioverter/defibrillator system by medial sternotomy techniques


name: Implantation or replacement of the total automatic cardioverter/defibrillator system by subxiphoid procedure techniques


name: Partial resection of vessel with replacement


name: Endovascular thrombectomy of pre-cerebral and cerebral vessels


name: Percutaneous ablation of liver lesion or tissue


name: Laparoscopic ablation of liver lesion or tissue


name: Other and unspecified ablation of liver lesion or tissue


name: Percutaneous ablation of renal lesion or tissue


name: Laparoscopic ablation of renal lesion or tissue


name: Other and unspecified ablation of renal lesion or tissue


name: Fetal reduction of multiple fetuses reduced to single fetus


name: Other and unspecified subtotal abdominal hysterectomy


name: Laparoscopic total abdominal hysterectomy


name: Other and unspecified vaginal hysterectomy


name: Laparoscopic radical abdominal hysterectomy


name: Laparoscopic modified radical hysterectomy


name: Total laparoscopic radical hysterectomy [TLRH]


name: Other and unspecified radical abdominal hysterectomy


name: Other and unspecified radical vaginal hysterectomy


name: Vaginal hysterectomy, radical (Schauta type operation)


name: Computer (assisted) (dependent) external fixator device


name: Testing of female for genetic disease carrier status


name: Testing of male for genetic disease carrier status


name: PERSONS WITHOUT REPORTED DIAGNOSIS ENCOUNTERED DURING EXAMINATION AND INVESTIGATION OF INDIVIDUALS AND POPULATIONS


name: Screening for genetic disease carrier status


name: Other and unspecified total abdominal hysterectomy


name: Insertion of catheter(s) into cranial cavity or tissue


name: Endovascular removal of obstruction from head and neck vessel(s)


name: Hip resurfacing arthroplasty, partial, acetabulum


name: Laparoscopic radical vaginal hysterectomy [LRVH]


name: magnesium carbonate / sodium bicarbonate


name: Descemet Stripping Endothelial Keratoplasty


name: A4beta2 acetylcholine receptor partial agonist (product)


name: magnesium hydroxide / omeprazole / sodium bicarbonate


name: choline salicylate, glycerol drug combination


name: activated charcoal / magnesium hydroxide


name: Cardiac Intraventricular Route of Administration


name: Substance with antifilarial mechanism of action


name: Cholinergic receptor stimulating preparation


name: Proprioceptive Neuromuscular Facilitation (PNF) Stretching


name: Magnetic Resonance Imaging, Interventional


name: {90 (insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]) } Pack [Exubera Combination Pack 12]


name: {180 (insulin human, rDNA origin 1 MG Inhalation Powder [Exubera]) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder [Exubera]) } Pack [Exubera Kit]


name: Efavirenz- and emtricitabine- and tenofovir-containing product


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Sronyx 28 Day]


name: {51 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: Beta-2 Glycoprotein Antibody Measurement


name: {35 (dexamethasone 1.5 MG Oral Tablet) } Pack


name: Joint survey, single view, 2 or more joints (specify)


name: Thromboendarterectomy, including patch graft, if performed; tibioperoneal trunk artery


name: Helmet, protective, soft, custom fabricated, includes all components and accessories


name: Thromboendarterectomy, including patch graft, if performed; popliteal artery


name: Bypass graft, with other than vein; aortobi-iliac


name: Interspinous process distraction device (implantable)


name: Helmet, protective, hard, prefabricated, includes all components and accessories


name: Insertion of implants into the soft palate; minimum of three implants


name: Thromboendarterectomy, including patch graft, if performed; superficial femoral artery


name: Helmet, protective, soft, prefabricated, includes all components and accessories


name: Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure


name: Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or catheter with related venography radiologic supervision and interpretation, and radiographic documentation of final catheter position) (List separately in addition to code for primary procedure)


name: Computed tomography, bone mineral density study, 1 or more sites, axial skeleton (eg, hips, pelvis, spine)


name: Spirometry results documented and reviewed (COPD)


name: Long-term oxygen therapy prescribed (more than 15 hours per day) (COPD)


name: Thromboendarterectomy, including patch graft, if performed; tibial or peroneal artery, initial vessel


name: Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft


name: Surgical dressing holder, non-reusable, each


name: Helmet, protective, hard, custom fabricated, includes all components and accessories


name: Intermittent limb compression device (includes all accessories), not otherwise specified


name: Power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each


name: Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each


name: Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)


name: Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg


name: Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams


name: Power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 2 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 standard, seat elevator, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 3 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 3 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 4 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 5 pediatric, multiple power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds


name: Terminal device, hand, mechanical, voluntary opening, any material, any size


name: Hospice care provided in long term care facility


name: Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each


name: Power wheelchair accessory, foam caster tire, any size, replacement only, each


name: Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)


name: Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg


name: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram


name: Power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 2 standard, portable, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601 pounds or more


name: Power wheelchair, group 2 extra heavy duty, single power option, sling/solid seat/back, patient weight capacity 601 pounds or more


name: Power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 3 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 5 pediatric, single power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds


name: Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined


name: External recharging system for battery (external) for use with implantable neurostimulator, replacement only


name: Hospice care provided in inpatient hospice facility


name: Computerized corneal topography, unilateral or bilateral, with interpretation and report


name: Whole body integumentary photography, for monitoring of high risk patients with dysplastic nevus syndrome or a history of dysplastic nevi, or patients with a personal or familial history of melanoma


name: Colorectal cancer screening results documented and reviewed (PV)


name: Continuous passive motion exercise device for use other than knee


name: Power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each


name: Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each


name: Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)


name: Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg


name: Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams


name: Power operated vehicle, not otherwise classified


name: Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 standard, seat elevator, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more


name: Power wheelchair, group 3 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 4 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, not otherwise classified


name: Addition to upper extremity prosthesis, external powered, additional switch, any type


name: Terminal device, hand, mechanical, voluntary closing, any material, any size


name: Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)


name: Hospice care provided in inpatient psychiatric facility


name: Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only


name: Power wheelchair accessory, foam filled caster tire, any size, replacement only, each


name: POWER WHEELCHAIR ACCESSORY, CASTER WHEEL EXCLUDES TIRE, ANY SIZE, REPLACEMENT ONLY, EACH


name: Trauma response team associated with hospital critical care service


name: Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram


name: Power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)


name: Power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 1 standard, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 2 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 3 heavy duty, single power option, sling/solid seat/back, patient weight 301 to 450 pounds


name: Power wheelchair, group 4 standard, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 4 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds


name: Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment


name: Terminal device, sport/recreational/work attachment, any material, any size


name: Auditory osseointegrated device, includes all internal and external components procedure


name: Hospice care provided in skilled nursing facility (snf)


name: Antipsychotic pharmacotherapy prescribed (MDD)


name: Magnetic resonance imaging guidance for, and monitoring of, parenchymal tissue ablation


name: Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; appendicular skeleton (peripheral) (eg, radius, wrist, heel)


name: Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus with interpretation and report


name: Pneumococcus immunization status assessed (CAP, COPD)


name: Vital signs (temperature, pulse, respiratory rate, and blood pressure) documented and reviewed (CAP) (EM)


name: Sleeve for intermittent limb compression device, replacement only, each


name: Computed tomography guidance for, and monitoring of, parenchymal tissue ablation


name: Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)


name: Neurofunctional testing selection and administration during noninvasive imaging functional brain mapping, with test administered entirely by a physician or other qualified health care professional (ie, psychologist), with review of test results and report


name: Coupling gel or paste, for use with ultrasound device, per oz


name: Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified


name: Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue


name: Power wheelchair accessory, foam drive wheel tire, any size, replacement only, each


name: Power wheelchair accessory, caster fork, any size, replacement only, each


name: Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg


name: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram


name: Power operated vehicle, group 2 standard, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 standard, portable, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more


name: Power wheelchair, group 2 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 3 heavy duty, captains chair, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 3 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 4 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined


name: Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each


name: Hospice care provided in inpatient hospital


name: Power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only


name: Power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each


name: Power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each


name: Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram


name: Power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 1 standard, sling/solid seat and back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 2 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 3 standard, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 3 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 4 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 4 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment


name: Terminal device, passive hand/mitt, any material, any size


name: Electric hook, switch or myoelectric controlled, adult


name: Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)


name: Etonogestrel (contraceptive) implant system, including implant and supplies


name: Antidepressant pharmacotherapy prescribed (MDD, MDD ADOL)


name: Power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only


name: POWER WHEELCHAIR ACCESSORY, TUBE FOR PNEUMATIC CASTER TIRE, ANY SIZE, REPLACEMENT ONLY, EACH


name: Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)


name: Alcohol and/or drug services, brief intervention, per 15 minutes


name: Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram


name: Power operated vehicle, group 1 standard, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 heavy duty, captains chair, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 2 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 3 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 3 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 601 pounds or more


name: Power wheelchair, group 4 very heavy duty, single power option, sling/solid seat/back, patient weight 451 to 600 pounds


name: Cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment


name: Electric hand, switch or myoelectric, controlled, pediatric


name: Persistent asthma (mild, moderate or severe) (Asthma)


name: Thromboendarterectomy, including patch graft, if performed; each additional tibial or peroneal artery (List separately in addition to code for primary procedure)


name: Surgical dressing holder, reusable, each


name: Soft interface for helmet, replacement only


name: Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Japanese Edition


name: Power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware


name: POWER WHEELCHAIR ACCESSORY, PNEUMATIC CASTER TIRE, ANY SIZE, REPLACEMENT ONLY, EACH


name: Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each


name: Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)


name: Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram


name: Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams


name: PORTABLE GASEOUS OXYGEN SYSTEM, RENTAL; HOME COMPRESSOR USED TO FILL PORTABLE OXYGEN CYLINDERS; INCLUDES PORTABLE CONTAINERS, REGULATOR, FLOWMETER, HUMIDIFIER, CANNULA OR MASK, AND TUBING


name: Power wheelchair, group 1 standard, portable, sling/solid seat and back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 2 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds


name: Power wheelchair, group 2 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Power wheelchair, group 3 extra heavy duty, captains chair, patient weight capacity 601 pounds or more


name: Power wheelchair, group 3 very heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds


name: Power wheelchair, group 4 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds


name: Power mobility device, not coded by dme pdac or does not meet criteria


name: Upper extremity addition, flexion/extension and rotation wrist unit


name: Electric hand, switch or myoelectric controlled, adult


name: Hospice or home health care provided in place not otherwise specified (nos)


name: establishment and maintenance of localization


name: Deprecated Heart Scintigraphy perfusion at rest & W stress & W Tc-99m Sestamibi IV


name: sensory perception, sensory transduction of heat stimulus


name: baroreceptor feedback control of blood pressure


name: regulation of systemic arterial blood pressure by circulatory renin-angiotensin


name: angiotensin mediated vasoconstriction during blood pressure control


name: renal response to blood flow during renin-angiotensin control of blood pressure


name: renin-angiotensin control of body fluid levels


name: regulation of renal output by angiotensin


name: regulation of border follicle cell delamination


name: negative regulation of chitin-based cuticle tanning


name: positive regulation of cuticle hardening


name: Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue


name: Deprecated BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method


name: Deprecated Basophils/100 leukocytes in Body fluid by Manual count


name: Deprecated Bilirubin [Mass/volume] in Body fluid


name: Deprecated CD23 cells/100 cells in Unspecified specimen


name: Deprecated CD235a cells/100 cells in Unspecified specimen


name: Deprecated CD30 Ag [Presence] in Tissue by Immune stain


name: Deprecated CD5 cells [#/volume] in Blood


name: Deprecated CD5+CD19+ cells [#/volume] in Blood


name: Deprecated CD56 cells/100 cells in Unspecified specimen


name: Deprecated CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal


name: Deprecated Cytomegalovirus Ab [Titer] in Serum


name: Deprecated Cytomegalovirus Ab [Titer] in Serum by Latex agglutination


name: Deprecated Carbon dioxide [Molecules/volume] in Body fluid


name: Deprecated Campylobacter sp identified in Unspecified specimen by Organism specific culture


name: Deprecated Casts [#/area] in Urine sediment by Microscopy high power field


name: Deprecated Cefepime [Susceptibility] by Disk diffusion (KB)


name: Deprecated Cefpirome [Susceptibility] by Disk diffusion (KB)


name: Deprecated Chlamydia sp Ab [Titer] in Serum by Complement fixation


name: Deprecated Cholesterol [Mass/volume] in Body fluid


name: Deprecated Cholesterol [Mass/volume] in Pleural fluid


name: Deprecated Benzoylmethylecgonine [Mass/volume] in Urine


name: Deprecated Collection duration of Urine - time unspecified


name: Deprecated Creatinine [Mass/volume] in Body fluid


name: Deprecated Microscopic observation [Identifier] in Tissue by Dark field examination


name: Deprecated Eastern equine encephalitis virus Ab [Titer] in Serum


name: Deprecated Eosinophils/100 leukocytes in Body fluid by Manual count


name: Deprecated Estradiol [Mass/volume] in Saliva


name: Deprecated Helicobacter pylori Ab [Titer] in Serum


name: Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification


name: Deprecated HLA-B27 [Presence] in Blood from donor


name: Deprecated HLA-B35 [Presence] in Blood from donor


name: Deprecated Haemophilus influenzae C Ag [Presence] in Unspecified specimen by Immunofluorescence


name: Deprecated Herbicide [Identifier] in Unspecified specimen


name: Deprecated Insulin [Units/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO


name: Deprecated La Crosse virus IgG Ab [Titer] in Serum


name: Deprecated La Crosse virus IgM Ab [Titer] in Serum


name: Deprecated Lymphocytes/100 leukocytes in Body fluid by Manual count


name: Deprecated Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe


name: Deprecated Nairobi sheep disease virus Ab [Titer] in Serum


name: Deprecated Neutrophils [#/volume] in Blood by Automated count


name: Deprecated Neutrophils/100 leukocytes in Body fluid by Manual count


name: Deprecated Pasteurella multocida serotype [Identifier] in Unspecified specimen by Agglutination


name: Deprecated Phosphate [Mass/volume] in Body fluid


name: Deprecated Platelets [#/volume] in Blood by Automated count


name: Deprecated Rabies virus Ag [Units/volume] in Tissue by Immunofluorescence


name: Deprecated Rabies virus Ag [Units/volume] in Unspecified specimen by Immunofluorescence


name: Deprecated Rabies virus strain identified in Tissue by Organism specific culture


name: Deprecated Rabies virus strain identified in Unspecified specimen by Organism specific culture


name: Deprecated Salmonella sp identified in Unspecified specimen by Organism specific culture


name: Deprecated Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain


name: Deprecated Spermatozoa [#/volume] in Semen


name: Deprecated Spermatozoa Ab [Units/volume] in Semen


name: Deprecated Spermatozoa Motile/100 spermatozoa in Semen


name: Deprecated Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Agglutination


name: Deprecated Urate [Mass/volume] in Body fluid


name: Deprecated Western equine encephalitis virus Ab [Titer] in Serum


name: Deprecated t(15,17)(PML,RARA) Translocation [Presence] in Blood or Tissue by Molecular genetics method


name: Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain


name: Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain


name: Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain


name: Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain


name: Views^W Tc-99m tagged RBC IV:Find:Pt:Abdomen>Liver:Doc:NM


name: aspirin / citric acid / sodium bicarbonate


name: Alka-Seltzer Plus Cold and Cough Reformulated Mar 2007


name: Measurement of lipoprotein-associated phospholipase A2 (Lp-PLA2)


name: Metathesaurus FDA Structured Product Labels


name: CONTACT LENS (FOR HARD LENS) SOAKING SOLUTION


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Balziva 28 Day]


name: {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Quasense 91 Day]


name: {180 (insulin human, rDNA origin 1 MG Inhalation Powder) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder) } Pack


name: IRRIGATING SYRINGE CATHETER 60ML KENDALL #8881560141


name: {21 (prednisone 10 MG Oral Tablet) } Pack


name: {48 (prednisone 10 MG Oral Tablet) } Pack


name: {48 (prednisone 5 MG Oral Tablet) } Pack


name: CATHERIZATION SET,INTERMITTENT 10FR BARD #4A5110


name: CATHERIZATION SET,INTERMITTENT 10FR H#96104


name: CATHERIZATION SET,INTERMITTENT 12FR BARD #4A5142


name: CATHERIZATION SET,INTERMITTENT 12FR H#96124


name: CATHERIZATION SET,INTERMITTENT 14FR BARD #4A5144


name: CATHERIZATION SET,INTERMITTENT 14FR H#96144


name: CATHERIZATION SET,INTERMITTENT 16FR H#96164


name: CATHERIZATION SET,INTERMITTENT 18FR H#96184


name: CATHERIZATION SET,INTERMITTENT 6FR H#96064


name: CATHERIZATION SET,INTERMITTENT 8FR BARD #4A5108


name: CATHERIZATION SET,INTERMITTENT 8FR H#96084


name: CATHETER,INTERMITTENT 12FR RUSCH #221800-12


name: CATHETER,INTERMITTENT 14FR RUSCH #221800-14


name: CATHETER,INTERMITTENT 16FR RUSCH #221800-16


name: CATHETER,INTERMITTENT 18FR RUSCH #221800-18


name: DRESSING,COVADERM 4IN X 10IN DEROYAL #46-004


name: DRESSING,COVADERM 4IN X 14IN DEROYAL #46-005


name: DRESSING,COVADERM 4IN X 4IN DEROYAL #46-001


name: DRESSING,COVADERM 4IN X 6IN DEROYAL #46-002


name: DRESSING,COVADERM 4IN X 8IN DEROYAL #46-003


name: DRESSING,OIL EMULSION 5IN X 9IN KEN#6116


name: DRESSING,SILVERCEL 4.25IN X 4.25IN JJ#800404


name: DRESSING,SOFSORB 3IN X 3IN DEROYAL#46-109


name: DRESSING,SOFSORB 4IN X 6IN DEROYAL#46-101


name: DRESSING,SOFSORB 4IN X 9IN DEROYAL#46-106


name: NON-ADHESIVE UROSTOMY SYSTEM LARGE #501002


name: NON-ADHESIVE UROSTOMY SYSTEM SMALL #501000


name: TAPE,MEDIPORE SOFT CLOTH 1IN X 10YD 3M #2961


name: TAPE,MEDIPORE SOFT CLOTH 2IN X 10YD 3M #2962


name: TAPE,MEDIPORE SOFT CLOTH 3IN X 10YD 3M #2963


name: TAPE,MEDIPORE SOFT CLOTH 4IN X 10YD 3M #2964


name: TAPE,MEDIPORE SOFT CLOTH 6IN X 10YD 3M #2966


name: TAPE,MEDIPORE SOFT CLOTH 8IN X 10YD 3M #2968


name: UNDERPAD,BED,WASHABLE 30IN X 34IN PRIVA #P11604


name: UNDERPAD,BED,WASHABLE 30IN X 34IN PRIVA #P7204


name: UNDERPAD,BED,WASHABLE 34IN X 36IN KENAD #61-8020/10


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P12205


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P12605


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P12605H


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P13205


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P13605


name: UNDERPAD,BED,WASHABLE 34IN X 52IN PRIVA #P12606


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Nora-BE 28 Day]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Ortho Micronor 28 Day]


name: {12 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Aranelle 28]


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) } Pack [Lo/Ovral 21 Day]


name: {7 (desogestrel 0.1 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.125 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.15 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Cesia 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Cryselle 28]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Jolessa 91 Day]


name: {21 (ethinyl estradiol 0.035 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Kelnor 1/35 28 Day]


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Lutera 28 Day]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Microgestin 1/20 21 Day]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Microgestin Fe 1/20 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [MonoNessa 28 Day]


name: {10 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 11 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Necon 10/11 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 0.75 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nortrel 7/7/7 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nortrel 1/35 28 Day]


name: {21 (ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Ogestrel 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Portia 28 Day]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Reclipsen 28 Day]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Solia 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Sprintec 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Previfem 28 Day]


name: {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Yaz 28 Day]


name: {6 (0.2 ML interferon beta-1a 0.044 MG/ML Prefilled Syringe [Rebif]) / 6 (0.5 ML interferon beta-1a 0.044 MG/ML Prefilled Syringe [Rebif]) } Pack [Rebif Titration]


name: UNDERPAD,BED 23IN X 36IN REASSURE PREMIUM


name: UNDERPAD,BED 30IN X 36IN REASSURE PREMIUM


name: DEXTRANOMER MICROSPHERES (DEFLUX) 50MG/ML SYR,1ML


name: dexbrompheniramine / hydrocodone / phenylephrine


name: regulation of multicellular organismal process


name: general adaptation syndrome, behavioral process


name: regulation of sensory perception of pain


name: regulation of nervous system development


name: repression of premature neural plate formation


name: somatic diversification of immune receptors


name: somatic diversification of DSCAM-based immune receptors


name: somatic diversification of variable lymphocyte receptors of jawless fish


name: innate immune response activating cell surface receptor signaling pathway


name: pattern recognition receptor signaling pathway


name: stimulatory killer cell immunoglobulin-like receptor signaling pathway


name: detection of endoplasmic reticulum overloading


name: imaginal disc-derived genitalia development


name: imaginal disc-derived male genitalia development


name: imaginal disc-derived female genitalia development


name: myo-inositol hexakisphosphate biosynthetic process


name: regulation of tissue kallikrein-kinin cascade


name: somatic diversification of immunoglobulins


name: antigen sampling in mucosal-associated lymphoid tissue


name: antigen transport in mucosal-associated lymphoid tissue


name: antigen sampling by dendritic cells in mucosal-associated lymphoid tissue


name: antigen sampling by M cells in mucosal-associated lymphoid tissue


name: immunoglobulin production in mucosal tissue


name: immune response-activating cell surface receptor signaling pathway


name: Fc receptor mediated stimulatory signaling pathway


name: immune complex clearance by erythrocytes


name: immune complex clearance by monocytes and macrophages


name: production of molecular mediator of immune response


name: production of cellular mediator of immune response


name: regulation of plasma kallikrein-kinin cascade


name: smoothened signaling pathway involved in ventral spinal cord interneuron specification


name: smoothened signaling pathway involved in spinal cord motor neuron cell fate specification


name: Wnt signaling pathway involved in forebrain neuroblast division


name: fibroblast growth factor receptor signaling pathway involved in forebrain neuroblast division


name: Notch signaling pathway involved in forebrain neuroblast division


name: fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment


name: fibroblast growth factor receptor signaling pathway involved in spinal cord anterior/posterior pattern formation


name: smoothened signaling pathway involved in ventral spinal cord patterning


name: regulation of cell proliferation in dorsal spinal cord


name: regulation of cerebellar granule cell precursor proliferation


name: smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation


name: negative regulation of anterior neural cell fate commitment of the neural plate by fibroblast growth factor receptor signaling pathway


name: leukemia inhibitory factor signaling pathway involved in forebrain neuron fate commitment


name: epidermal growth factor signaling pathway involved in forebrain neuron fate commitment


name: regulation of anatomical structure morphogenesis


name: multicellular organism adhesion to substrate


name: somatic diversification of immune receptors via somatic mutation


name: somatic diversification of FREP-based immune receptors


name: somatic diversification of T cell receptor genes


name: somatic diversification of immune receptors by N region addition


name: somatic diversification of immunoglobulin genes by N region addition


name: somatic diversification of T cell receptor genes by N region addition


name: regulation of antigen processing and presentation


name: regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II


name: regulation of antigen processing and presentation of peptide antigen


name: regulation of antigen processing and presentation of peptide antigen via MHC class II


name: regulation of antigen processing and presentation of peptide antigen via MHC class I


name: regulation of antigen processing and presentation via MHC class Ib


name: regulation of antigen processing and presentation of peptide antigen via MHC class Ib


name: regulation of antigen processing and presentation of lipid antigen via MHC class Ib


name: regulation of antigen processing and presentation of polysaccharide antigen via MHC class II


name: regulation of proteolysis associated with antigen processing and presentation


name: regulation of central tolerance induction


name: regulation of peripheral tolerance induction


name: regulation of B cell tolerance induction


name: regulation of production of molecular mediator of immune response


name: regulation of leukocyte mediated immunity


name: regulation of lymphocyte mediated immunity


name: regulation of monoatomic ion transmembrane transporter activity


name: negative regulation of ion transmembrane transporter activity


name: active evasion of host immune response via regulation of host complement system


name: regulation of natural killer cell mediated immunity


name: cell surface pattern recognition receptor signaling pathway


name: MyD88-dependent toll-like receptor signaling pathway


name: MyD88-independent toll-like receptor signaling pathway


name: immune response-activating signaling pathway


name: regulation of antimicrobial humoral response


name: immune response-inhibiting signal transduction


name: innate immune response-inhibiting signal transduction


name: immune response-inhibiting cell surface receptor signaling pathway


name: Fc receptor mediated inhibitory signaling pathway


name: regulation of antimicrobial peptide production


name: regulation of antibacterial peptide production


name: regulation of antifungal peptide production


name: regulation of antimicrobial peptide biosynthetic process


name: regulation of antibacterial peptide biosynthetic process


name: regulation of antifungal peptide biosynthetic process


name: regulation of myeloid leukocyte mediated immunity


name: regulation of axon extension involved in regeneration


name: leukemia inhibitory factor signaling pathway


name: homeostasis of number of cells in a free-living population


name: Margin reflex distance (observable entity)


name: bismuth biskalcitrate / metronidazole / tetracycline


name: Advance diet as tolerated (regime/therapy)


name: albuterol, beclomethasone drug combinations


name: Instillation of dilating eye drops to eye


name: DRESSING,OPSITE IV3000 FRAME 2 3/8IN X 2 3/4IN SN#59410082


name: {28 (ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack [Femhrt 0.5/2.5 28 Day]


name: IRRIGATING SYRINGE,PISTON CATHETER TIP 60ML


name: {15 (estradiol 1 MG / norgestimate 0.09 MG Oral Tablet) / 15 (estradiol 1 MG Oral Tablet) } Pack [Prefest 30 Day]


name: Syagrus romanzoffianum Ab.IgE.RAST class


name: 1.5 hours post dose luteinizing releasing hormone IV


name: 15 minutes post dose growth hormone releasing factor


name: 15 minutes post dose luteinizing releasing hormone IV


name: 15 minutes pre dose luteinizing releasing hormone IV


name: 1 hour post dose growth hormone releasing factor


name: 1 hour post dose luteinizing releasing hormone IV


name: 2.5 hours post 100 ug luteinizing releasing hormone IV


name: 2.5 hours post dose propranolol+glucagon


name: 2 hours post dose growth hormone releasing factor


name: 2 hours post dose luteinizing releasing hormone IV


name: 30 minutes post dose growth hormone releasing factor


name: 30 minutes post dose luteinizing releasing hormone IV


name: 45 minutes post dose growth hormone releasing factor


name: 7 minutes post 0.5 ug/kg pentagastrin IV


name: 8 hours post 8 mg dexamethasone PO overnight high dose


name: immediately after addition of bovine thrombin


name: post 2 mg dexamethasone PO 2.5 day high dose q6h


name: post 500 ug dexamethasone PO 2.5 day low dose q6h


name: pre 100 ug luteinizing releasing hormone IV


name: pre dose growth hormone releasing factor


name: pre dose luteinizing releasing hormone IV


name: Bacterial vaginosis & vaginitis rRNA panel


name: Guidance for percutaneous replacement of drainage catheter


name: human immunodeficiency virus care & family status section


name: Multisection sagittal & coronal disarticulation


name: Outpatient encounter-level information section


name: Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG panel


name: Nucleic acid amplification detection limit = 200 copies/ml


name: Outcome and Assessment Information Survey set


name: Aware of normal hazards & take appropriate precautions:Find:Pt:^Patient:Ord:RFC assessment


name: Travels in unfamiliar places or use public transportation:Find:Pt:^Patient:Ord:RFC assessment


name: Sets realistic goals or make plans independently of others:Find:Pt:^Patient:Ord:RFC assessment


name: Functional capacity assessment:Find:Pt:^Patient:Nar:RFC assessment


name: Residual physical functional capacity (RFC) assessment form:-:Pt:^Patient:-:RFC assessment


name: Residual physical functional capacity (RFC) assessment form


name: IP CDB claim numberholder:ID:Pt:^Patient:Nom:RFC assessment


name: Follow-up contact supplemental information


name: Outcome and Assessment Information Set (OASIS)


name: Residual Functional Capacity Assessment (RFC)


name: Vasopressin^1st specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Chlamydia trachomatis L2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Cholesterol.in LDL real size pattern:Prid:Pt:Ser/Plas:Nom


name: Hepatitis B virus DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 200 copies/mL


name: Hepatitis C virus Ab:PrThr:Pt:Ser^Donor:Ord:IA


name: Views GE 4 && Views:Find:Pt:Chest:Doc:XR && RF


name: Views GE 4 + PA + lateral:Find:Pt:Chest:Doc:XR


name: Multisection blood pool^W radionuclide IV:Find:Pt:Abdomen>Liver:Doc:NM.SPECT


name: Guidance for change of percutaneous tube^W contrast:Find:Pt:XXX:Doc:XR


name: Guidance for percutaneous drainage+placement of drainage catheter:Find:Pt:Abdomen>Biliary ducts:Doc:RF


name: Guidance for placement of tube^W radionuclide IV:Find:Pt:Chest:Doc:NM.SPECT


name: Views PA^W standing + W flexion:Find:Pt:Lower extremity.bilateral>Knee:Doc:XR


name: Multisection:Find:Pt:Upper extremity.bilateral>Upper extremity vessels:Doc:US.doppler


name: ABO & Rh group^post transfusion reaction:Type:Pt:Bld^BPU:Nom


name: ABO group^post transfusion reaction:Type:Pt:Bld:Nom


name: Blood group antibody^post transfusion reaction:PrThr:Pt:Ser/Plas:Ord:Blood group antibody screen


name: Xylose^15M post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn


name: Norepinephrine^4th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Norepinephrine^5th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Norepinephrine^5th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Norepinephrine^6th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Norepinephrine^6th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Catecholamines^7th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Norepinephrine^7th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon:ACnc:Pt:Bld^Control:Qn


name: Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells:ACnc:Pt:Bld:Qn


name: Coagulation thrombin induced^after addition of heparinase:Time:Pt:PPP:Qn:Coag


name: ABCA3 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: SGCA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Chief complaint+Reason for visit:Find:Pt:^Patient:Nar


name: Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis katG gene isoniazid high level resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis embB gene ethambutol resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Borrelia burgdorferi Ab.IgG & IgM:Imp:Pt:Ser:Nom:IA


name: Bordetella pertussis.filamentous hemagglutinin Ab.IgG:ACnc:Pt:Ser:Qn:IF


name: Bordetella pertussis.pertussis toxin Ab.IgG:ACnc:Pt:Ser:Qn:IF


name: History of medical device use:Find:Pt:{Setting}:Doc:{Role}


name: Direct antiglobulin test.polyspecific reagent^post transfusion reaction:PrThr:Pt:RBC:Ord


name: Major crossmatch^post transfusion reaction:Imp:Pt:Ser/Plas:Nom


name: Rh immune globulin given by:ID:Pt:Provider:Nom


name: Views for bone density:ArMass:Pt:Lower extremity.left>Hip:Qn:DXA


name: Views for bone density:ArMass:Pt:Lower extremity.right>Hip:Qn:DXA


name: Deprecated Radius & Ulna right DEXA Bone density


name: Guidance for aspiration or injection of cyst:Find:Pt:XXX:Doc:CT


name: Guidance for aspiration or injection of cyst:Find:Pt:XXX:Doc:US


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Breast.right:Doc:MG


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Breast.left:Doc:MG


name: Guidance for biopsy.core needle:Find:Pt:Neck>Thyroid gland:Doc:US


name: Deprecated CT Guidance for needle biopsy of Unspecified body region


name: Guidance for percutaneous biopsy^WO & W contrast IV:Find:Pt:XXX:Doc:CT


name: Guidance for percutaneous biopsy^WO contrast:Find:Pt:XXX:Doc:CT


name: Guidance for drainage+placement of drainage catheter^WO & W contrast IV:Find:Pt:XXX:Doc:CT


name: Guidance for drainage+placement of drainage catheter^W contrast IV:Find:Pt:XXX:Doc:CT


name: Guidance for drainage+placement of drainage catheter^WO contrast:Find:Pt:XXX:Doc:CT


name: Guidance for percutaneous replacement of drainage catheter:Find:Pt:Abdomen>Stomach:Doc:RF


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Breast.left:Doc:MG.stereotactic


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Breast:Doc:MG.stereotactic


name: Multisection^W radionuclide IV:Find:Pt:Whole body:Doc:NM.SPECT


name: Multisection limited:Find:Pt:Upper extremity.bilateral>Upper extremity artery:Doc:US.doppler


name: Multisection limited:Find:Pt:Upper extremity>Upper extremity vessels:Doc:US.doppler


name: Multisection^W contrast IV:Find:Pt:Whole body:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Lower extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Lower extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.right>Upper extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Head>Orbit+Face & Neck:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Neck>Parotid gland:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.left>Upper extremity vessels:Doc:CT.angio


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Pelvis:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Head>Internal auditory canal:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Head>Maxillofacial region:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Head:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Chest:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Abdomen:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Upper extremity>Elbow:Doc:MR


name: Multisection^W contrast IV:Find:Pt:Head>Orbit+Face & Neck:Doc:MR


name: Multisection^W contrast IV:Find:Pt:Lower extremity>Lower extremity vessels:Doc:MR.angio


name: Multisection^W reduced contrast volume IV:Find:Pt:Head>Internal auditory canal:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Head>Maxillofacial region:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Chest:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Head:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Pelvis:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Abdomen:Doc:CT


name: Multisection^WO contrast:Find:Pt:Head>Orbit+Face & Neck:Doc:MR


name: Views GE 3:Find:Pt:Upper extremity.right>Wrist:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.left>Elbow:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.right>Elbow:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.left>Wrist:Doc:XR


name: Views GE 3:Find:Pt:Lower extremity.right>Ankle:Doc:XR


name: Views GE 2 + PA + lateral:Find:Pt:Chest:Doc:XR


name: Views AP + transthoracic:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR


name: Views displacement for implant:Find:Pt:Breast.bilateral:Doc:MG


name: Views^during surgery W contrast intra duct:Find:Pt:Breast>Breast duct:Doc:MG


name: Views^W air contrast PR:Find:Pt:Abdomen+Pelvis>Colon:Doc:RF


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aortic arch:Doc:MR.angio


name: Views ventilation^W Xe-133 IH:Find:Pt:Chest>Lung:Doc:NM


name: Multisection:Find:Pt:Lower extremity>Lower extremity vein:Doc:US


name: Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity vein:Doc:US


name: Guidance for ablation of tissue:Find:Pt:Abdomen>Celiac plexus:Doc:CT


name: Guidance for percutaneous biopsy^W radionuclide IV:Find:Pt:XXX>Bone:Doc:NM.SPECT


name: Views for bone density:ArMass:Pt:XXX>Bone:Qn:DXA


name: Guidance for superficial biopsy^W radionuclide IV:Find:Pt:XXX>Bone:Doc:NM.SPECT


name: Multisection for graft:Find:Pt:Upper extremity>Upper extremity vessel:Doc:US.doppler


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Breast:Doc:MG


name: Views GE 3:Find:Pt:Lower extremity.left>Ankle:Doc:XR


name: Multisection gated+ejection fraction^at rest+W stress+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection gated^at rest+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Cortisol^15M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1.5H post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^2H post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Corticotropin^15M post 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^1.5H post 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^2H post 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn


name: Cortisol^2H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^2H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M pre 1 g/kg glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M post 1 g/kg glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^1.5H post 1 g/kg glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M pre dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^45M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^105M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^7M post 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Lutropin^15M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^45M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Cortisol^8H post 8 mg dexamethasone PO overnight high dose:MCnc:Pt:Ser/Plas:Qn


name: Coagulation tissue factor induced:Time:Pt:BldC:Qn:Coag


name: Coagulation tissue factor induced.INR:RelTime:Pt:BldC:Qn:Coag


name: Hydrogen/Expired gas^post 50 g lactose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^post 10 g lactulose PO:VFr:Pt:Exhl gas:Qn


name: t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG:Imp:Pt:Ser:Nom


name: Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG panel:ACnc:Pt:Ser:Qn


name: Cancer identification section:-:Pt:^Patient:Set:NAACCR v.11


name: Edit overrides &or Conversion history &or System admin section:-:Pt:^Patient:Set:NAACCR v.11


name: Edit overrides &or Conversion history &or System admin section


name: Follow-up &or Recurrence &or Death section:-:Pt:^Patient:Set:NAACCR v.11


name: Follow-up &or Recurrence &or Death section


name: Record ID section:-:Pt:^Patient:Set:NAACCR v.11


name: Special use section:-:Pt:^Patient:Set:NAACCR v.11


name: Stage &or prognostic factors section:-:Pt:^Patient:Set:NAACCR v.11


name: Treatment-1st course section:-:Pt:^Patient:Set:NAACCR v.11


name: Treatment-subsequent & other section:-:Pt:^Patient:Set:NAACCR v.11


name: Shigella sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: Changed medical regimen diagnoses:-:Pt:^Patient:-


name: Number of pressure injuries at each stage:-:Pt:^Patient:-


name: Deprecated Outcome and assessment information set (OASIS) form - version B1


name: Current payment sources for home care:Find:Pt:^Patient:Nom:OASIS


name: Conditions prior to medical or treatment regimen change or inpatient stay within past 14D:Find:14D:^Patient:Nom:OASIS


name: Therapeutic substance administered at home:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Assisting person(s) other than home care agency staff:Find:Pt:^Patient:Nom:OASIS


name: Type of primary caregiver assistance:-:Pt:^Patient:-


name: At home respiratory treatments:Find:Pt:^Patient:Nom:OASIS


name: Cognitive, behavioral, and psychiatric symptoms demonstrated at least one time per W:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Discharge support services or assistance:Find:Pt:^Patient:Nom:OASIS


name: Discharge support services or assistance


name: Reason for nursing home admission:Find:Pt:^Patient:Nom:OASIS


name: Ability to dress upper body:-:Pt:^Patient:-


name: Ability to dress lower body:-:Pt:^Patient:-


name: Planning & preparing light meals:-:Pt:^Patient:-


name: Ability to use telephone:-:Pt:^Patient:-


name: Management of oral medications:-:Pt:^Patient:-


name: Management of inhalant &or mist medications:-:Pt:^Patient:-


name: Management of inhalant &or mist medications


name: State location of agency branch:Loc:RptPeriod:Agency:Nom:CMS Assessment


name: Agency patient number:ID:RptPeriod:^Patient:Nom:CMS Assessment


name: Start of care date:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Resumption of care date:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Discipline of person completing assessment:Type:RptPeriod:Provider:Nom:CMS Assessment


name: Date assessment information completed:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Deprecated Most recent inpatient discharge date [OASIS]


name: Inpatient stay within last 14D - ICD code:Prid:14D:^Patient:Nom:CMS Assessment


name: Inpatient stay within last 14D - ICD code^^^2:Prid:14D:^Patient:Nom:OASIS


name: Medical or treatment regimen change in past 14D:Find:14D:^Patient:Ord:OASIS


name: Regimen change in past 14D - ICD code:Prid:14D:^Patient:Nom:CMS Assessment


name: Regimen change in past 14D - ICD code^^^2:Prid:14D:^Patient:Nom:OASIS


name: Regimen change in past 14D - ICD code^^^3:Prid:14D:^Patient:Nom:OASIS


name: Regimen change in past 14D - ICD code ^^^4:Prid:14D:^Patient:Nom:OASIS


name: Primary diagnosis severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 1 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 1 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 2 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 2 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 3 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 3 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 4 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 4 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 5 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 5 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Overall prognosis for recovery from this episode:Find:Pt:^Patient:Ord:OASIS


name: Frequency of primary caregiver assistance:Find:Pt:^Patient:Ord:OASIS


name: Sensory status - vision:Find:Pt:^Patient:Ord:OASIS


name: Sensory status - hearing and ability to understand spoken language:Find:Pt:^Patient:Ord:OASIS


name: Sensory status - speech and oral expression of language:Find:Pt:^Patient:Ord:OASIS


name: Sensory status - frequency of pain:Find:Pt:^Patient:Ord:OASIS


name: Skin lesion or open wound:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of pressure injuries - stage 1:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of pressure ulcers - stage 2:Num:Pt:^Patient:Qn:OASIS


name: Number of pressure ulcers - stage 3:Num:Pt:^Patient:Qn:OASIS


name: Number of pressure ulcers - stage 4:Num:Pt:^Patient:Qn:OASIS


name: Stage of most problematic pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Status of most problematic pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Number of stasis ulcers:Num:Pt:^Patient:Qn:OASIS


name: Unobserved stasis pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Status of most problematic stasis pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Number of surgical wounds:Num:Pt:^Patient:Qn:OASIS


name: Status of most problematic surgical wound:Find:Pt:^Patient:Ord:OASIS


name: When short of breath:Find:Pt:^Patient:Ord:OASIS


name: Treated for urinary tract infection in past 14D:Find:14D:^Patient:Ord:CMS Assessment


name: Urinary incontinence or urinary catheter present:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Current ability - ambulation:Find:Pt:^Patient:Ord:OASIS


name: Current ability - feeding:Find:Pt:^Patient:Ord:OASIS


name: Prior - prepare light meals:Find:Pt:^Patient:Ord:OASIS


name: Current ability - prepare light meals:Find:Pt:^Patient:Ord:OASIS


name: Current ability - transportation:Find:Pt:^Patient:Ord:OASIS


name: Current ability - laundry:Find:Pt:^Patient:Ord:OASIS


name: Current ability - housekeeping:Find:Pt:^Patient:Ord:OASIS


name: Current ability - shopping:Find:Pt:^Patient:Ord:OASIS


name: Prior - telephone use:Find:Pt:^Patient:Ord:OASIS


name: Telephone use - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Prior - management of oral medications:Find:Pt:^Patient:Ord:OASIS


name: Current ability - management of oral medications:Find:Pt:^Patient:Ord:OASIS


name: Prior - management of inhalant medications:Find:Pt:^Patient:Ord:OASIS


name: Current ability - management of inhalant medications:Find:Pt:^Patient:Ord:OASIS


name: Prior - management of injectable medications:Find:Pt:^Patient:Ord:OASIS


name: Current ability - management of injectable medications:Find:Pt:^Patient:Ord:OASIS


name: Admitted to:Type:RptPeriod:Inpatient facility:Nom:CMS Assessment


name: Acute care hospitalization reason:Find:Pt:^Patient:Ord:OASIS


name: Date of last home visit:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Discharge, transfer, death date:Date:Pt:^Patient:Qn


name: Payment diagnosis - primary ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Payment diagnosis - first secondary ICD:Prid:Pt:^Patient:Nom:OASIS


name: When urinary incontinence occurs:Find:Pt:^Patient:Ord:OASIS


name: Bowel incontinence frequency:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Ostomy for bowel elimination:Find:Pt:^Patient:Ord:OASIS


name: Frequency of behavior problems:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Receives psychiatric nursing:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Grooming - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Prior - dress upper body:Find:Pt:^Patient:Ord:OASIS


name: Dress upper body - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Prior - dress lower body:Find:Pt:^Patient:Ord:OASIS


name: Dress lower body - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Current ability - bathing:Find:Pt:^Patient:Ord:OASIS


name: Current ability - toileting:Find:Pt:^Patient:Ord:OASIS


name: Current ability - transferring:Find:Pt:^Patient:Ord:OASIS


name: Primary referring physician ID:ID:Pt:Provider:Nom


name: Diagnosis and severity index:-:Pt:^Patient:-


name: Mental residual functional capacity (RFC) assessment form:-:Pt:^Patient:-


name: Mental residual functional capacity (RFC) assessment form


name: Remembers locations & worklike procedures:Find:Pt:^Patient:Ord:RFC assessment


name: Understands & remembers very short & simple instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Understands & remembers detailed instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Carries out very short & simple instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Carries out detailed instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Maintains attention & concentration for extended periods:Find:Pt:^Patient:Ord:RFC assessment


name: Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances:Find:Pt:^Patient:Ord:RFC assessment


name: Sustains an ordinary routine without special supervision:Find:Pt:^Patient:Ord:RFC assessment


name: Works in coordination with or proximity to others without being distracted by them:Find:Pt:^Patient:Ord:RFC assessment


name: Makes simple work-related decisions:Find:Pt:^Patient:Ord:RFC assessment


name: Completes normal workday & week WO interruptions from psych symptoms & performs at consistent pace WO unreasonable number & length of rests:Find:Pt:^Patient:Ord:RFC assessment


name: Interacts appropriately with the general public:Find:Pt:^Patient:Ord:RFC assessment


name: Asks simple questions or request assistance:Find:Pt:^Patient:Ord:RFC assessment


name: Accepts instructions & respond appropriately to criticism from supervisors:Find:Pt:^Patient:Ord:RFC assessment


name: Gets along with coworkers or peers WO distracting them or exhibiting behavioral extremes:Find:Pt:^Patient:Ord:RFC assessment


name: Maintains socially appropriate behavior & adheres to basic standards of neatness & cleanliness:Find:Pt:^Patient:Ord:RFC assessment


name: Responds appropriately to changes in the work setting:Find:Pt:^Patient:Ord:RFC assessment


name: Other alleged impairments:Imp:Pt:^Patient:Nar:RFC assessment


name: No exertional limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Occasionally lift &or carry:Find:Pt:^Patient:Ord:RFC assessment


name: Frequently lift &or carry:Find:Pt:^Patient:Ord:RFC assessment


name: Stand &or walk:Find:Pt:^Patient:Ord:RFC assessment


name: Push &or pull:Find:Pt:^Patient:Ord:RFC assessment


name: No postural limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: No manipulative limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Reaching in all directions:Find:Pt:^Patient:Ord:RFC assessment


name: No visual limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Field of vision:Find:Pt:^Patient:Ord:RFC assessment


name: No communicative limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Fumes, odors, dusts, gases, poor ventilation, etc:Find:Pt:^Patient:Ord:RFC assessment


name: Treatment or examining source statements:-:Pt:^Patient:Set:RFC assessment


name: Treatment or examining source statements


name: Treating or examining source statement regarding claimant's physical capacities in file:Arb:Pt:^Patient:Ord:RFC assessment


name: Treating or examining source statement regarding claimant's physical capacities in file


name: Treating or examining source conclusions about the claimant's limitations or restrictions which are significantly different from your file:Arb:Pt:^Patient:Nom:RFC assessment


name: Treating or examining source conclusions about the claimant's limitations or restrictions which are significantly different from your file


name: Why conclusions are not supported by the evidence in file:Imp:Pt:^Patient:Nar:RFC assessment


name: Why conclusions are not supported by the evidence in file


name: Fibroblast growth factor 23:ACnc:Pt:Plas:Qn


name: Clostridium botulinum toxin gene:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Clostridium perfringens toxin gene:Prid:Pt:XXX:Nom:Probe.amp.tar


name: (Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Solidago virgaurea+Urtica dioica) Ab.IgE:MCnc:Pt:Ser:Qn:Multidisk


name: (Beef+Chicken meat+Pork+Turkey meat) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Brassica oleracea var italica+Daucus carota+Phaseolus vulgaris+Pisum sativum+Zea mays) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Gadus morhua+Mytilus edulis+Pandalus borealis+Salmo salar+Thunnus albacares) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Malus sylvestris+Musa spp+Prunus persica+Pyrus communis) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Coagulation thrombin induced.factor substitution^immediately after addition of bovine thrombin:Time:Pt:PPP:Qn:Coag


name: Aquaporin 4 water channel Ab.IgG:PrThr:Pt:CSF:Ord


name: Streptomycin 4.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria


name: HTR2A gene+HTR2C gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Deprecated Prolactin monomeric [Mass/volume] in Serum or Plasma


name: Bacterial vaginosis whiff test:PrThr:Pt:Vag:Ord


name: RHCE gene allele Cc:Geno:Pt:Amnio fld:Nom:Molgen


name: Citrullinemias &or arginosuccinic aciduria:Imp:Pt:Bld.dot:Nom


name: Fatty acid oxidation defects:Imp:Pt:Bld.dot:Nom


name: Glutaric acidemia type 1:Imp:Pt:Bld.dot:Nom


name: Homocystinuria &or other hypermethioninemias:Imp:Pt:Bld.dot:Ord


name: Isovaleric acidemia &or 2-Methylbutyric acidemia:Imp:Pt:Bld.dot:Nom


name: Maple syrup urine disease:Imp:Pt:Bld.dot:Nom


name: Phenylketonuria and variants &or biopterin defects:Imp:Pt:Bld.dot:Nom


name: Propionic &or methylmalonic acidemias:Imp:Pt:Bld.dot:Nom


name: 3-Methylcrotonic &or hydroxymethylglutaric &or methylglutaconic:Imp:Pt:Bld.dot:Ord


name: 2-Methyl-3-Hydroxybutyric acidemias &or beta ketothiolase deficiency:Imp:Pt:Bld.dot:Nom


name: Medium chain acyl dehydrogenase deficiency &or glutaric acidemia type 2:Imp:Pt:Bld.dot:Ord


name: Very long chain hydroxy acyl dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom


name: Long chain hydroxy acyl dehydrogenase &or trifunctional protein deficiencies:Imp:Pt:Bld.dot:Nom


name: Carnitine uptake defect &or CPT1 deficiency:Imp:Pt:Bld.dot:Ord


name: Other fatty acid oxidation disorders:Imp:Pt:Bld.dot:Ord


name: Hb SS, Hb SC, Hb SB thal:Imp:Pt:Bld.dot:Ord


name: Thyroid binding globulin deficiency:Imp:Pt:Bld.dot:Ord


name: Hemoglobin S beta thalassemia:Imp:Pt:Bld.dot:Ord


name: Sickle cell carrier (trait):Imp:Pt:Bld.dot:Ord


name: Carnitine palmitoyltransferase 1 deficiency:Imp:Pt:Bld.dot:Nom


name: Glutaric acidemia 2 &or ethylmalonic encephalopathy:Imp:Pt:Bld.dot:Nom


name: Medium &or short chain acyl-CoA dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom


name: Short-chain acyl-CoA deficiency &or ethylmalonic encephalopathy &or isobutyryl-CoA dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom


name: Communicable &or infectious condition function.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communication with community resources.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communication with community resources.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communication with community resources.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Neighborhood &or workplace safety.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Neighborhood &or workplace safety.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Neighborhood &or workplace safety.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Sleep and rest pattern.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Sleep and rest pattern.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Sleep and rest pattern.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.behavior:Find:Pt:^Family:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.knowledge:Find:Pt:^Family:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.status:Find:Pt:^Family:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.behavior:Find:Pt:^Patient:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.knowledge:Find:Pt:^Patient:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.status:Find:Pt:^Patient:Ord:Observed.OMAHA


name: TCR alpha beta Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: TCR gamma delta Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Vasoactive intestinal peptide Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: MCOLN1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Haemophilus influenzae B Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Haemophilus influenzae B Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn:IA


name: Haemophilus influenzae B Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Influenza virus B Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Views GE 3:Find:Pt:Upper extremity.left>Hand:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.right>Hand:Doc:XR


name: Views 1 or 2:Find:Pt:Lower extremity.left>Knee:Doc:XR


name: Views GE 4:Find:Pt:Lower extremity.left>Knee:Doc:XR


name: Views 1 or 2:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Views GE 4:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Views LE 4:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Liver kidney microsomal Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: GBA gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CFTR gene targeted mutation analysis:Find:Pt:Amnio fld:Doc:Molgen


name: ASPA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BLM gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: DYS gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: TCRB & Immunoglobulin heavy chain gene rearrangements:Find:Pt:Bld/Tiss:Doc:Molgen


name: Bacterial vaginosis & vaginitis rRNA panel:-:Pt:Vag:-:Probe


name: Varicella zoster virus DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Cancer Ag 72-4:PrThr:Pt:Tiss:Ord:Immune stain


name: Choriogonadotropin.beta subunit Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cytokeratin 5+6 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cytokeratin HMW Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Streptococcus pneumoniae Danish serotype 9V Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn:IA


name: Admission history and physical note:Find:Pt:Hospital:Doc:{Role}


name: Summary of death note:Find:Pt:{Setting}:Doc:{Role}


name: Diagnostic interventional radiology study:Find:Pt:^Patient:Doc:Interventional radiology


name: Herpes virus 8 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 10 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 11 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 11 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 12 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 12 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 13 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 13 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 14 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 14 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Epstein Barr virus capsid Ab.IgG:Titr:Pt:Body fld:SemiQn:IF


name: Epstein Barr virus capsid Ab.IgM:Titr:Pt:Body fld:SemiQn:IF


name: Epstein Barr virus early Ab.IgG:Titr:Pt:Body fld:SemiQn:IF


name: Epstein Barr virus early Ab.IgA:Titr:Pt:Ser:SemiQn:IF


name: PCNA extractable nuclear Ab:PrThr:Pt:Ser:Ord:IF


name: Coxiella burnetii phase 1 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 7 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 7 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 8 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 8 Ab.IgM:Titr:Pt:Ser:SemiQn:IF